Similar companies
| Company | Stocktwits Subscribers | |
|---|---|---|
 |
AmgenAMGN |
13,842 0% |
 |
Gilead SciencesGILD |
77,122 0% |
 |
Catalyst PharmaceuticalsCPRX |
15,571 0% |
 |
Inovio PharmaceuticalsINO |
93,315 0% |
 |
Anavex Life SciencesAVXL |
20,393 0% |
Month over Month
Subscribing Stocktwits Users
| Oct 2024 | 9,800 | |
| Sep 2024 | 9,778 | |
| Aug 2024 | 9,772 | |
| Jul 2024 | 9,780 | |
| Jun 2024 | 9,783 |
How many users are following Celldex Therapeutics on StockTwits?
The interest in Celldex Therapeutics on StockTwits is minor, with a following of 9,805 investors.
Analyzing Stocktwits Subscribers, how is Celldex Therapeutics performing compared to its industry peers?
Celldex Therapeutics underperforms its industry peers when it comes to Stocktwits Subscribers, ranking in the 6th percentile.
What has been the change in Celldex Therapeutics' StockTwits followers over the past month?
There has been no meaningful change in the number of followers in the last month.
What is StockTwits?
StockTwits is a social media platform designed specifically for the investing community. It enables investors and traders to share market insights, strategies, and real-time news updates. Essentially, it's a specialized network for financial market discussions, often characterized by brief, tweet-like posts.
Why is it important for Celldex Therapeutics investors to monitor its StockTwits followers?
For investors in Celldex Therapeutics, tracking the number of followers on StockTwits can be highly beneficial. The platform's follower count offers a direct gauge of investor interest and sentiment surrounding Ford. An increasing follower count typically suggests growing investor attention and can be an indicator of rising market enthusiasm or concern about the company's prospects. This data can provide investors with valuable insights into market trends, potential shifts in investor behavior, and broader perceptions of Ford in the investment community.
Sign up and get more insights on Celldex Therapeutics.
